Suppr超能文献

[日本老年患者幽门螺杆菌的根除治疗]

[Eradication therapy of Helicobacter pylori for elderly patients in Japan].

作者信息

Nakamura Tetsuya, Terano Akira

机构信息

Division of Endoscopy, Center for Photomedicine.

出版信息

Nihon Rinsho. 2002 Aug;60(8):1566-72.

Abstract

In Japan, an eradication therapy of Helicobacter pylori(H. pylori) for peptic ulcers of stomach and duodenum was approved by a health insurance since November 1, 2000. A method of an eradication therapy is as follows. Adult patients are received lansoprazole 30 mg, amoxicillin 750 mg, clarithromycin 200-400 mg at the same time twice daily for seven days. This therapy is based on a guideline of a Japanese association of Helicobacter Research. Many elderly patients have complications such as hypertension, cerebral vascular disturbance, heart failure and so on. Moreover, they often take a several medicine including NSAIDs(non-steroidal anti-inflammatory drugs). Therefore, you should pay attention especially to interaction of drugs when planning an eradication therapy of H. pylori for elderly patients.

摘要

自2000年11月1日起,日本一项针对胃及十二指肠消化性溃疡的幽门螺杆菌根除疗法被纳入健康保险。根除疗法如下:成年患者同时服用兰索拉唑30毫克、阿莫西林750毫克、克拉霉素200 - 400毫克,每日两次,持续七天。该疗法基于日本幽门螺杆菌研究协会的指南。许多老年患者患有高血压、脑血管疾病、心力衰竭等并发症。此外,他们经常服用包括非甾体抗炎药在内的多种药物。因此,在为老年患者规划幽门螺杆菌根除疗法时,应特别注意药物相互作用。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验